Abstract
Pyoderma gangrenosum (PG) is a distinctive ulcerative skin disorder of unknown etiology, associated with an underlying systemic disease in up to 70% of cases. The condition is characterized by the appearance of one or more necrotic ulcers with a ragged undermined violaceous border and surrounding erythema. Lesions are often initiated by minor trauma. The condition can affect any anatomical site, however the head and neck are rarely involved. Although the oral cavity is subject to recurrent minor trauma through everyday activities such as mastication and oral hygiene, as well as during dental treatment, oral lesions appear to be extremely rare. In an effort to provide a detailed explanation of the oral manifestations of PG, a systematic search was conducted using medical databases. A total of 20 cases of PG with oral involvement were reported in the English and French literature. The objectives of this article are to present the pertinent diagnostic criteria and to discuss the differential diagnosis and therapeutic modalities.
Similar content being viewed by others
References
Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55(217):173–86.
Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800. doi:10.1111/j.1365-4632.2004.02128.x.
von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137(6):1000–5.
Kiran RP, O’Brien-Ermlich B, Achkar JP, Fazio VW, Delaney CP. Management of peristomal Pyoderma gangrenosum. Dis Colon Rectum. 2005;48(7):1397–403. doi:10.1007/s10350-004-0944-x.
Setterfield JF, Shirlaw PJ, Challacombe SJ, Black MM. Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia. Br J Dermatol. 2001;144(2):393–6.
Lazarus GS, Goldsmith LA, Rocklin RE, Pinals RS, de Buisseret JP, David JR. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol. 1972;105(1):46–51.
Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34(3):395–409 (quiz 10–2).
Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of Pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73(4):691–8. doi:10.1016/j.jaad.2015.06.021.
Bhat RM. Pyoderma gangrenosum: An update. Indian Dermatol Online J. 2012;3(1):7–13. doi:10.4103/2229-5178.93482.
Yco MS, Warnock GR, Cruickshank JC, Burnett JR. Pyoderma gangrenosum involving the head and neck. Laryngoscope. 1988;98(7):765–8. doi:10.1288/00005537-198807000-00016.
Al Ghazal P, Dissemond J. Multilocular Pyoderma gangrenosum after uterus resection. Chirurg. 2012;83(3):254–7.
Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol. 1980;9(2):307–21.
Drinda S, Oelzner P, Codina Canet C, Kaatz M, Wolf G, Hein G. Fatal outcome of Pyoderma gangrenosum with multiple organ involvement and partially responding to Infliximab. Cent Eur J Med. 2006;1(3):306–12. doi:10.2478/s11536-006-0024-9.
Margoles JS, Wenger J. Stomal ulceration associated with Pyoderma gangrenosum and chronic ulcerative colitis. Report of two cases. Gastroenterology. 1961;41:594–8.
Tsuboi H. Case of Pyoderma gangrenosum showing oral and genital ulcers, misdiagnosed as Behcet’s disease at first medical examination. J Dermatol. 2008;35(5):289–92. doi:10.1111/j.1346-8138.2008.00468.x.
Goulden V, Bond L, Highet AS. Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol. 1994;19(3):271–3.
Hernandez-Martin A, Arias-Palomo D, Hermida G, Gutierrez-Ortega MC, Ramirez-Herrera M, Rodriguez-Vegas M, et al. Oral Pyoderma gangrenosum. Br J Dermatol. 2003;149(3):663–4.
Park HJ, Han BG, Kim YC, Cinn YW. Recalcitrant oral Pyoderma gangrenosum in a child responsive to cyclosporine. J Dermatol. 2003;30(8):612–6.
Buckley C, Bayoumi AH, Sarkany I. Pyoderma gangrenosum with severe pharyngeal ulceration. J R Soc Med. 1990;83(9):590–1.
Poiraud C, Gagey-Caron V, Barbarot S, Durant C, Ayari S, Stalder JF. Cutaneous, mucosal and systemic Pyoderma gangrenosum. Ann Dermatol Venereol. 2010;137(3):212–5. doi:10.1016/j.annder.2010.01.007.
Curi MM, Cardoso CL, Koga DH, Zardetto C, Araújo SR. Pyoderma gangrenosum affecting the mouth. Open J Stomatol. 2013;3(2):4.
Verma S, Field S, Murphy G. Photoletter to the editor: oral ulceration in Pyoderma gangrenosum. J Dermatol Case Rep. 2011;5(2):34–5. doi:10.3315/jdcr.2011.1070.
Chariatte N, Lysitsa S, Lombardi T, Samson J. Pyoderma gangrenosum (2ème partie): manifestations buccales et présentation d’un cas. Med Buccale Chir Buccale. 2011;17(3):225–35.
Paramkusam G, Meduri V, Gangeshetty N. Pyoderma gangrenosum with oral involvement: case report and review of the literature. Int J Oral Sci. 2010;2(2):111–6. doi:10.4248/ijos10032.
Bertram-Callens A, Machet L, Vaillant L, Camenen I, Lorette G. Buccal and ocular localizations of Pyoderma gangrenosum in Vaquez’s disease. Ann Dermatol Venereol. 1991;118(9):611–4.
Kennedy KS, Prendergast ML, Sooy CD. Pyoderma gangrenosum of the oral cavity, nose, and larynx. Otolaryngol Head Neck Surg. 1987;97(5):487–90.
Yusuf H, Ead RD. Pyoderma gangrenosum with involvement of the tongue. Br J Oral Maxillofac Surg. 1985;23(4):247–50.
Zampeli VA, Lippert U, Nikolakis G, Makrantonaki E, Tzellos TG, Krause U, et al. Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab. J Dermatol Case Rep. 2015;9(3):62–6. doi:10.3315/jdcr.2015.1206.
Al Attas KM, Ahsan MK, Buraik M, Gamal AM, Hannani HY. Fatal pyoderma gangrenosum in a patient with inflammatory bowel disease and hypogonadotropic hypogonadism: case report. J Saudi Soc Dermatol Dermatol Surg. 2013;17(2):4.
Isomura I, Miyawaki S, Morita A. Pyoderma gangrenosum associated with nasal septal perforation, oropharyngeal ulcers and IgA paraproteinemia. J Dermatol. 2005;32(3):193–8.
Kaomongkolgit R, Subbalekha K, Sawangarun W, Thongprasom K. Pyoderma gangrenosum-like oral ulcerations in an elderly patient. Gerodontology. 2015;32(4):309–13. doi:10.1111/ger.12158.
Siddiqui S, Fiorillo M, Tismenetsky M, Spinnell M. Isolated oral Pyoderma gangrenosum following proctocolectomy. Am J Gastroenterol. 2012;107:S517–S8.
Callen JP, Taylor WB. Pyoderma gangrenosum: a literature review. Cutis. 1978;21(1):61–4.
Philpott JA Jr, Goltz RW, Park RK. Pyoderma gangrenosum, rheumatoid arthritis, and diabetes mellitus. Arch Dermatol. 1966;94(6):732–8.
DeFilippis EM, Feldman SR, Huang WW. The genetics of Pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol. 2015;172(6):1487–97. doi:10.1111/bjd.13493.
Tolkachjov SN, Fahy AS, Wetter DA, Brough KR, Bridges AG, Davis MD, et al. Postoperative Pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol. 2015;73(4):615–22. doi:10.1016/j.jaad.2015.06.054.
Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH): a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66(3):409–15. doi:10.1016/j.jaad.2010.12.025.
Hong JB, Su YN, Chiu HC. Pyogenic arthritis, Pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol. 2009;61(3):533–5. doi:10.1016/j.jaad.2008.11.017.
Calderon-Castrat X, Bancalari-Diaz D, Roman-Curto C, Romo-Melgar A, Amoros-Cerdan D, L AA-M, et al. PSTPIP1 gene mutation in a Pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2015. doi:10.1111/bjd.14383.
Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C. Pyogenic arthritis, Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013;149(6):762–4. doi:10.1001/jamadermatol.2013.2907.
Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis: W. B. Saunders; 2016.
Hirshberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126(4):522–9. doi:10.1309/afha406gbt0n2y64.
Sirois DA, Miller AS, Harwick RD, Vonderheid EC. Oral manifestations of cutaneous T cell lymphoma. A report of eight cases. Oral Surg Oral Med Oral Pathol. 1993;75(6):700–5.
Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener’s granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol. 2007;34(10):739–47. doi:10.1111/j.1600-0560.2006.00699.x.
Wang WC, Chen JY, Chen YK, Lin LM. Tuberculosis of the head and neck: a review of 20 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(3):381–6. doi:10.1016/j.tripleo.2008.11.002.
Wallach D, Vignon-Pennamen MD. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. 2015. doi:10.1111/bjd.13955.
Amouri M, Masmoudi A, Ammar M, Boudaya S, Khabir A, Boudawara T, et al. Sweet’s syndrome: a retrospective study of 90 cases from a tertiary care center. Int J Dermatol. 2016. doi:10.1111/ijd.13232.
The International Criteria for Behcet’s Disease (ICBD). A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47. doi:10.1111/jdv.12107.
Gibson LE, Daoud MS, Muller SA, Perry HO. Malignant pyodermas revisited. Mayo Clin Proc. 1997;72(8):734–6. doi:10.1016/s0025-6196(11)63593-3.
Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for Pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53(2):273–83. doi:10.1016/j.jaad.2004.10.006.
Zuo KJ, Fung E, Tredget EE, Lin AN. A systematic review of post-surgical Pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg. 2015;68(3):295–303. doi:10.1016/j.bjps.2014.12.036.
Marzano AV, Alberti-Violetti S, Crippa R, Angiero F, Tadini G, Crosti C. Pyoderma gangrenosum with severe cutaneous and oral involvement. Eur J Dermatol. 2013;23(2):257–8. doi:10.1684/ejd.2013.1968.
Snyder RA. Pyoderma gangrenosum involving the head and neck. Arch Dermatol. 1986;122(3):295–302.
Baloch BK, Baloch SK, Kumar S, Mansoor F, Jawad A. Orogenital ulcers of Pyoderma gangrenosum resembling sexually transmitted disease. J Coll Physicians Surg Pak. 2014;24 Suppl 3:S207–8.
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, et al. Comparison of the two most commonly used treatments for Pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. Bmj. 2015;350:h2958. doi:10.1136/bmj.h2958.
Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982–92. doi:10.1097/mib.0000000000000392.
Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, et al. Infliximab for the treatment of Pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–9. doi:10.1136/gut.2005.074815.
Agarwal A, Andrews JM. Systematic review: IBD-associated Pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther. 2013;38(6):563–72. doi:10.1111/apt.12431.
Ambooken B, Khader A, Muhammed K, Rajan U, Snigdha O. Malignant Pyoderma gangrenosum eroding the parotid gland successfully treated with dexamethasone pulse therapy. Int J Dermatol. 2014;53(12):1536–8. doi:10.1111/ijd.12519.
Ye MJ, Ye JM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract. 2014;2014:461467. doi:10.1155/2014/461467.
Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010;62(4):646–54. doi:10.1016/j.jaad.2009.05.030.
Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma (echthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol. 1930;22(4):655–80. doi:10.1001/archderm.1930.01440160053009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Caroline Bissonnette declares that she has no conflict of interest. Adel Kauzman declares that he has no conflict of interest. Gisele N. Mainville declares that she has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Bissonnette, C., Kauzman, A. & Mainville, G.N. Oral Pyoderma Gangrenosum: Diagnosis, Treatment and Challenges: A Systematic Review . Head and Neck Pathol 11, 427–441 (2017). https://doi.org/10.1007/s12105-017-0804-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-017-0804-3